Sentence examples for dose reduction factor from inspiring English sources

The dose reduction factor for survival was 2.47, and that for the production of DNA double-strand breaks was 2.42.

The dose reduction factor (DRF) for genistein is 1.16 when administered subcutaneous (sc).

In particular, the findings from NRRW-3 are consistent with the dose reduction factor of two commonly used when extrapolating leukaemia risks among the Japanese A-bomb survivors down to low doses (ICRP, 2007).

In addition, experiments utilising continuous low dose rate irradiation at 3.2 cGy min-1, showed that the cells possessed only a small capacity to recover from radiation damage (dose reduction factor at 1% cell survival of 1.15 for 150 versus 3.2 cGy min-1).

injection of a single dose of 17-DMAG (25 mg/kg) given to CD2F1 mice 24 h before a lethal dose of gamma-radiation at 8.75 Gy (i.e., LD70/30, a dose resulting in 70% of exposed population died within 30 days in a study [ 19]) improved mouse 30-day survival by 75 percentage points with a dose reduction factor (DRF) of 1.2 [ 20].

Furthermore, experiments utilising continuous low dose rate radiation at 3.2 cGy min-1, showed that, under these experimental conditions, the cells possessed only a very low capacity to recover from radiation-induced damage (dose reduction factor at 1% cell survival of 1.07 for 150 versus 3.2 cGy min-1).

Pediatric dose reduction factors were calculated on the basis of SSDEs for pediatric patients divided by SSDEs for adult patients.

Conclusion Diagnostic reference ranges developed in this study provided target ranges of pediatric dose indexes on the basis of patient size, while the pediatric dose reduction factors of this study allow calculation of unique reference dose indexes on the basis of patient size for each of a site's CT scanners.

The calculated dose-reduction factor (DRF) was 1.32 (TLR4+/− mice versus TLR4−/− mice).

To compare the GP collimator with the high-resolution collimator, a second acquisition was made for both collimators with a total acquisition time of 16 min. The initial analysis of BSGI scans of the 13 patients showed that a dose reduction by a factor of 3 would not have reduced the number of observable hotspots in each of the acquired views.

Moreover, the effects of medium-dose liposomal DxM-P (3 × 0.1 mg/kg) were equal (in the short term) or superior (in the long term) to those of high-dose free DxM-P (3 × 1 mg/kg), suggesting a potential dose reduction by a factor between 3 and 10 by liposomal encapsulation.